Setting new standards in information exchange for the pharmaceutical and biotech industry
Eli Lilly Confirmed to Discuss Trial Match “Patient 2 Trial” Progress @ Dpharm Europe
December 1, 2014
We are so pleased to welcome Thomas Krohn, Director, Lilly Open Innovation, Eli Lilly to Dpharm: Disruptive Innovations to Advance Clinical Trials Europe. Tom will give the latest update and progress on the Patients 2 Consortium effort between Lilly, Pfizer and Novartis. This effort is focused on enabling patients and those who serve patients to easily pre-screen patients to clinical studies, including using their electronic medical record such as a Blue Button+ document. Through consistent, structured clinical trial eligibility criteria made available through an open API technical platform, so-called “matching services” can be enabled to streamline patient engagement and potential clinical trial participation.
The update will include:
• What is “P2T” or Match project
• Where are we today and what is current focus and activity including end-user collaborations
• What types of end-user collaborations are in place, what have we learned, and anticipated benefits to end-users
• What are the key learnings we have had in the consortium that have helped move this project forward
Dpharm Europe takes place in London on February 10-11, 2015.